These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2770634)

  • 21. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
    Bannon EA; Yang Y; Rivard MJ
    Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose parameters of 125I and 192Ir seed sources.
    Weaver KA; Smith V; Huang D; Barnett C; Schell MC; Ling C
    Med Phys; 1989; 16(4):636-43. PubMed ID: 2770636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental measurements and Monte Carlo simulations of dose perturbation around a nonradioactive brachytherapy seed due to 6- and 18-MV photons.
    Steinman JP; Bakhtiari M; Malhotra HK
    Brachytherapy; 2012; 11(5):413-20. PubMed ID: 21737357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor dose specification of I-125 seed implants.
    Wu A; Zwicker RD; Sternick ES
    Med Phys; 1985; 12(1):27-31. PubMed ID: 3974522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant.
    Furstoss C; Reniers B; Bertrand MJ; Poon E; Carrier JF; Keller BM; Pignol JP; Beaulieu L; Verhaegen F
    Med Phys; 2009 May; 36(5):1848-58. PubMed ID: 19544804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-dimensional dose distribution around a commercial 125I seed.
    Burns GS; Raeside DE
    Med Phys; 1988; 15(1):56-60. PubMed ID: 3352551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interseed effects on dose for 125I brachytherapy implants.
    Meigooni AS; Meli JA; Nath R
    Med Phys; 1992; 19(2):385-90. PubMed ID: 1584137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetry for 131Cs and 125I seeds in solid water phantom using radiochromic EBT film.
    Chiu-Tsao ST; Napoli JJ; Davis SD; Hanley J; Rivard MJ
    Appl Radiat Isot; 2014 Sep; 92():102-14. PubMed ID: 25038559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
    Thomson RM; Taylor RE; Rogers DW
    Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric parameters for three low-energy brachytherapy sources using the Monte Carlo N-particle code.
    DeMarco JJ; Hugo G; Solberg TD
    Med Phys; 2002 May; 29(5):662-8. PubMed ID: 12033560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monte Carlo evaluation of specific dose constants in water for 125I seeds.
    Williamson JF
    Med Phys; 1988; 15(5):686-94. PubMed ID: 3185403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of improved TLD dosimetry on the determination of dose rate constants for (125)I and (103)Pd brachytherapy seeds.
    Rodriguez M; Rogers DW
    Med Phys; 2014 Nov; 41(11):114301. PubMed ID: 25370677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
    Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
    Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
    Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I25I brachytherapy source.
    Meigooni AS; Dini SA; Sowards K; Hayes JL; Al-Otoom A
    Med Phys; 2002 Jun; 29(6):939-42. PubMed ID: 12094988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Monte Carlo study on the effect of seed design on the interseed attenuation in permanent prostate implants.
    Afsharpour H; D'Amours M; Coté B; Carrier JF; Verhaegen F; Beaulieu L
    Med Phys; 2008 Aug; 35(8):3671-81. PubMed ID: 18777927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose rate determination for 125I seeds.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Sanna R
    Med Phys; 1990; 17(5):815-25. PubMed ID: 2233567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd.
    Lindsay P; Battista J; Van Dyk J
    Med Phys; 2001 Mar; 28(3):336-45. PubMed ID: 11318315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Monte Carlo investigation of lung brachytherapy treatment planning.
    Sutherland JG; Furutani KM; Thomson RM
    Phys Med Biol; 2013 Jul; 58(14):4763-80. PubMed ID: 23788118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.